Cell Therapy Innovation Symposium 2025
When
8. Oct12:00 PM - 05:00 PMWhere
Oslo Cancer Cluster Innovation Park, Kaare Norum Auditorium
Organizer
Thermo Fisher Scientific, The CellFit Project, with OCC
When
Where
Oslo Cancer Cluster Innovation Park, Kaare Norum Auditorium
Organizer
Thermo Fisher Scientific & Oslo Cancer Cluster, together with the CellFit Project invites you to join the Cell Therapy Innovation Symposium to explore the challenges and innovative solutions in immune cell therapy manufacturing. This symposium will engage experts and professionals involved in the design and manufacturing of immune cell therapies, including process developers, scientist, and lab managers.
A special feature will include a tour of OCC Innovation Park to highlight the recent expansion of this vibrant park anchored by Radium Hospital. The John Ugelstad building is under construction and expected to be completed by the end of 2025. The symposium’s organizing team will track the building progress and if possible, plan a tour (from inside or outside pending approvals).
About the co-organizer: Established in 2021, the CellFit Project is funded by The Research Council of Norway, a project led by Oslo University Hospital with project partners Oslo Cancer Cluster, SINTEF, and Thermo Fisher Scientific. The aim of the project is to improve the fitness of CAR T Cells by optimizing the manufacturing process.
Program Schedule
12:00–12:30
Registration & Lunch
12:30–12:40
Opening
Moderator: Else-Marit / Tuva
12:40–13:10
Ulrike Kohl – MD, PhD, Professor, Director, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig
Automated manufacturing of CAR effector cells: From viral to non-viral gene transfer
13:10–13:40
Nathalie Belmonte – PhD, Senior VP Research and Technical Development, Quell Therapeutics
Development of CAR-Treg therapies to modulate immune responses in transplantation and autoimmunity
13:40–14:10
Lamberto Torralba-Raga – Department of Cancer Immunology, Oslo University Hospital / Precision Immunotherapy Alliance, University of Oslo
Maximizing the innate power of NK cells in cancer therapy
14:10–14:40
Coffee Break
14:40–15:10
Manel Juan – Head of Section of Immunopathology Hospital Clínic Barcelona
Title Academic PoC production for improving patients' access to cell immunotherapy: ARI program from Barcelona as a model,
15:10–15:40
Anna Pasetto – PhD, Associate Professor, Director, Center for Advanced Cell Therapy (ACT), Oslo University Hospital
Solving CAR-T manufacturing and QC challenges with structured support and strategic solutions
15:40–16:15
Panel Discussion
Confirmed participants: Fredrik, Anna, Lamberto, Ulrike, Nathalie, Manel
Moderators; Hany Meås and Else Marit
16:15–17:00
Closing Remarks followed by mingling and fingerfood.
NOTE about a workshop the next day:
On October 9, 2025, 9am-5pm at OCC Innovation Park: You are invited to register your interest to join a specialized workshop conducted by Thermo Fisher Scientific. Please register your interest with corinna.pohl@thermofisher.com, who will contact you early Q3 2025 about the program.